Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure
Mario Tranfa(Amsterdam Neuroscience), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Gaël Chételat(Inserm), David Vállez García(Pasqual Maragall Foundation), Luigi Lorenzini(Amsterdam Neuroscience), Kaj Blennow(Sahlgrenska University Hospital), Giuseppe Pontillo(Amsterdam University Medical Centers), Craig Ritchie(Western General Hospital), Henk Mutsaerts(Amsterdam Neuroscience), Michael Ewers(German Center for Neurodegenerative Diseases), Carole H. Sudre(King's College London), Pierre Payoux(Université Toulouse III - Paul Sabatier), Pablo Martínez‐Lage(Fundacion CITA Alzheimer), Silvia Ingala(Amsterdam Neuroscience), Adam Waldman(Royal Society of Edinburgh), Alessio Maranzano(IRCCS Istituto Auxologico Italiano), Juan Domingo Gispert(Lund University), Alle Meije Wink(University of Cambridge), Sven Haller(Uppsala University), Adam J. Schwarz(Eli Lilly (United States)), Arturo Brunetti(Anna Needs Neuroblastoma Answers), Leonard Pieperhoff(Amsterdam Neuroscience), Robin Wolz(Ixico (United Kingdom)), Lyduine E. Collij(Lund University), Giovanni B. Frisoni(University of Geneva), Joanna M. Wardlaw(University of Edinburgh)
Cited by 18
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k